SIRT1 and atrial fibrillation: From a precision medicine perspective, targeting the molecular aftermath of alcohol exposure—such as restoring SIRT1 activity through pharmacologic activators (e.g., resveratrol)—may represent a promising adjunctive strategy in alcohol-associated AF.